Hippocampal-avoidance whole-brain radiation therapy: A new standard for patients with brain metastases?

Journal of Clinical Oncology

Volumn 32, Issue 34, 2014, Pages 3789-3791

  Suh, John H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM TEXAPHYRIN; MEMANTINE;

AGE DISTRIBUTION; ALZHEIMER DISEASE; BRAIN METASTASIS; BRAIN RADIATION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COGNITION; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DEMENTIA; DOUBLE BLIND PROCEDURE; EDITORIAL; EXECUTIVE FUNCTION; EXPERIMENTAL THERAPY; HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIATION THERAPY; HIPPOCAMPUS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NEURAL STEM CELL; NON SMALL CELL LUNG CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEREOTACTIC RADIOSURGERY; SURVIVAL TIME; BRAIN NEOPLASMS; FEMALE; MALE; MEMORY DISORDERS; PROCEDURES; RADIATION INJURIES; RADIATION RESPONSE; RECALL; SECONDARY; SKULL IRRADIATION;

BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MEMORY DISORDERS; MENTAL RECALL; NEURAL STEM CELLS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84912073096     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.4367     Document Type: Editorial

References (21)

1. Chao JH, Phillips R, Nickson JJ: Roentgen-ray therapy of cerebral metastases. Cancer 7:682-689, 1954
2. Borgelt B, Gelber R, Kramer S, et al: The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 6:1-9, 1980
3. Borgelt B, Gelber R, Larson M, et al: Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 7:1633-1638, 1981
4. Kurtz JM, Gelber R, Brady LW, et al: The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7:891-895, 1981
5. Murray KJ, Scott C, Greenberg HM, et al: A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 39:571-574, 1997
6. Sperduto PW, Chao ST, Sneed PK, et al: Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: A multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655-661, 2010
7. Barnholtz-Sloan JS, Yu C, Sloan AE, et al: A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro Oncol 14:910-918, 2012
8. Suh JH: Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 362:1119-1127, 2010
9. Suh JH, Videtic GM, Aref AM, et al: ACR appropriateness criteria: Single brain metastasis. Curr Probl Cancer 34:162-174, 2010
10. Mehta MP, Rodrigus P, Terhaard CH, et al: Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21:2529-2536, 2003
11. Meyers CA, Smith JA, Bezjak A, et al: Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial. J Clin Oncol 22:157-165, 2004
12. Li J, Bentzen SM, Renschler M, et al: Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 25:1260-1266, 2007
13. Sun A, Bae K, Gore EM, et al: Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: Neurocognitive and quality-of-life analysis. J Clin Oncol 29:279-286, 2011
14. Chang EL, Wefel JS, Hess KR, et al: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial. Lancet Oncol 10:1037-1044, 2009
15. Kocher M, Soffietti R, Abacioglu U, et al: Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952-26001 study. J Clin Oncol 29:134-141, 2011
16. Soffietti R, Kocher M, Abacioglu UM, et al: A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: Quality-of-life results. J Clin Oncol 31:65-72, 2013
17. Yamamoto M, Serizawa T, Shuto T, et al: Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): A multi-institutional prospective observational study. Lancet Oncol 15:387-395, 2014
18. Brown PD, Pugh S, Laack NN, et al: Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: A randomized, double-blind, placebo-controlled trial. Neuro Oncol 15:1429-1437, 2013
19. Gondi V, Pugh SL, Tome WA, et al: Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): A phase II multi-institutional trial. J Clin Oncol 32:3810-3816, 2014
20. Gondi V, Tomé WA, Mehta MP: Why avoid the hippocampus? A comprehensive review. Radiother Oncol 97:370-376, 2010
21. Gondi V, Tolakanahalli R, Mehta MP, et al: Hippocampal-sparing wholebrain radiotherapy: A "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 78:1244-1252, 2010